Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil

ABSTRACT OBJECTIVE To estimate the seroprevalence of antibodies to SARS-CoV-2 among blood donors in the state of Rio de Janeiro, Brazil. METHODS Data were collected on 2,857 blood donors from April 14 to 27, 2020. This study reports crude prevalence of antibodies to SARS-CoV-2, population weighted...

Full description

Bibliographic Details
Main Authors: Luiz Amorim Filho, Célia Landmann Szwarcwald, Sheila de Oliveira Garcia Mateos, Antonio Carlos Monteiro Ponce de Leon, Roberto de Andrade Medronho, Valdiléa Gonçalves Veloso, Josiane Iole França Lopes, Luis Cristovão de Moraes Sobrino Porto, Alexandre Chieppe, Guilherme Loureiro Werneck
Format: Article
Language:English
Published: Universidade de São Paulo 2020-07-01
Series:Revista de Saúde Pública
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102020000100251&tlng=en
_version_ 1818951140609359872
author Luiz Amorim Filho
Célia Landmann Szwarcwald
Sheila de Oliveira Garcia Mateos
Antonio Carlos Monteiro Ponce de Leon
Roberto de Andrade Medronho
Valdiléa Gonçalves Veloso
Josiane Iole França Lopes
Luis Cristovão de Moraes Sobrino Porto
Alexandre Chieppe
Guilherme Loureiro Werneck
author_facet Luiz Amorim Filho
Célia Landmann Szwarcwald
Sheila de Oliveira Garcia Mateos
Antonio Carlos Monteiro Ponce de Leon
Roberto de Andrade Medronho
Valdiléa Gonçalves Veloso
Josiane Iole França Lopes
Luis Cristovão de Moraes Sobrino Porto
Alexandre Chieppe
Guilherme Loureiro Werneck
author_sort Luiz Amorim Filho
collection DOAJ
description ABSTRACT OBJECTIVE To estimate the seroprevalence of antibodies to SARS-CoV-2 among blood donors in the state of Rio de Janeiro, Brazil. METHODS Data were collected on 2,857 blood donors from April 14 to 27, 2020. This study reports crude prevalence of antibodies to SARS-CoV-2, population weighted prevalence for the state, and prevalence adjusted for test sensitivity and specificity. Logistic regression models were used to establish the correlates of SARS-CoV-2 prevalence. For the analysis, we considered collection period and site, sociodemographic characteristics, and place of residence. RESULTS The proportion of positive tests for SARS-Cov-2, without any adjustment, was 4.0% (95%CI 3.3–4.7%), and the weighted prevalence was 3.8% (95%CI 3.1–4.5%). We found lower estimates after adjusting for test sensitivity and specificity: 3.6% (95%CI 2.7–4.4%) for the non-weighted prevalence, and 3.3% (95%CI 2.6–4.1%) for the weighted prevalence. Collection period was the variable most significantly associated with crude prevalence: the later the period, the higher the prevalence. Regarding sociodemographic characteristics, the younger the blood donor, the higher the prevalence, and the lower the education level, the higher the odds of testing positive for SARS-Cov-2 antibody. We found similar results for weighted prevalence. CONCLUSIONS Our findings comply with some basic premises: the increasing trend over time, as the epidemic curve in the state is still on the rise; and the higher prevalence among both the youngest, for moving around more than older age groups, and the less educated, for encountering more difficulties in following social distancing recommendations. Despite the study limitations, we may infer that Rio de Janeiro is far from reaching the required levels of herd immunity against SARS-CoV-2.
first_indexed 2024-12-20T09:29:45Z
format Article
id doaj.art-88cf8d0aea6243ee82ee4bed2af762fe
institution Directory Open Access Journal
issn 1518-8787
language English
last_indexed 2024-12-20T09:29:45Z
publishDate 2020-07-01
publisher Universidade de São Paulo
record_format Article
series Revista de Saúde Pública
spelling doaj.art-88cf8d0aea6243ee82ee4bed2af762fe2022-12-21T19:45:06ZengUniversidade de São PauloRevista de Saúde Pública1518-87872020-07-015410.11606/s1518-8787.2020054002643Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, BrazilLuiz Amorim Filhohttps://orcid.org/0000-0002-7714-3531Célia Landmann Szwarcwaldhttps://orcid.org/0000-0002-7798-2095Sheila de Oliveira Garcia Mateoshttps://orcid.org/0000-0001-5416-2724Antonio Carlos Monteiro Ponce de Leonhttps://orcid.org/0000-0002-0704-5215Roberto de Andrade Medronhohttps://orcid.org/0000-0003-4073-3930Valdiléa Gonçalves Velosohttps://orcid.org/0000-0002-6622-3165Josiane Iole França Lopeshttps://orcid.org/0000-0002-6347-5762Luis Cristovão de Moraes Sobrino Portohttps://orcid.org/0000-0003-1499-1821Alexandre Chieppehttps://orcid.org/0000-0003-4374-0810Guilherme Loureiro Werneckhttps://orcid.org/0000-0003-1169-1436ABSTRACT OBJECTIVE To estimate the seroprevalence of antibodies to SARS-CoV-2 among blood donors in the state of Rio de Janeiro, Brazil. METHODS Data were collected on 2,857 blood donors from April 14 to 27, 2020. This study reports crude prevalence of antibodies to SARS-CoV-2, population weighted prevalence for the state, and prevalence adjusted for test sensitivity and specificity. Logistic regression models were used to establish the correlates of SARS-CoV-2 prevalence. For the analysis, we considered collection period and site, sociodemographic characteristics, and place of residence. RESULTS The proportion of positive tests for SARS-Cov-2, without any adjustment, was 4.0% (95%CI 3.3–4.7%), and the weighted prevalence was 3.8% (95%CI 3.1–4.5%). We found lower estimates after adjusting for test sensitivity and specificity: 3.6% (95%CI 2.7–4.4%) for the non-weighted prevalence, and 3.3% (95%CI 2.6–4.1%) for the weighted prevalence. Collection period was the variable most significantly associated with crude prevalence: the later the period, the higher the prevalence. Regarding sociodemographic characteristics, the younger the blood donor, the higher the prevalence, and the lower the education level, the higher the odds of testing positive for SARS-Cov-2 antibody. We found similar results for weighted prevalence. CONCLUSIONS Our findings comply with some basic premises: the increasing trend over time, as the epidemic curve in the state is still on the rise; and the higher prevalence among both the youngest, for moving around more than older age groups, and the less educated, for encountering more difficulties in following social distancing recommendations. Despite the study limitations, we may infer that Rio de Janeiro is far from reaching the required levels of herd immunity against SARS-CoV-2.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102020000100251&tlng=enCoronavirus Infections, immunologyBlood DonorsSerologic TestsSeroepidemiologic Studies
spellingShingle Luiz Amorim Filho
Célia Landmann Szwarcwald
Sheila de Oliveira Garcia Mateos
Antonio Carlos Monteiro Ponce de Leon
Roberto de Andrade Medronho
Valdiléa Gonçalves Veloso
Josiane Iole França Lopes
Luis Cristovão de Moraes Sobrino Porto
Alexandre Chieppe
Guilherme Loureiro Werneck
Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
Revista de Saúde Pública
Coronavirus Infections, immunology
Blood Donors
Serologic Tests
Seroepidemiologic Studies
title Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
title_full Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
title_fullStr Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
title_full_unstemmed Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
title_short Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
title_sort seroprevalence of anti sars cov 2 among blood donors in rio de janeiro brazil
topic Coronavirus Infections, immunology
Blood Donors
Serologic Tests
Seroepidemiologic Studies
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102020000100251&tlng=en
work_keys_str_mv AT luizamorimfilho seroprevalenceofantisarscov2amongblooddonorsinriodejaneirobrazil
AT celialandmannszwarcwald seroprevalenceofantisarscov2amongblooddonorsinriodejaneirobrazil
AT sheiladeoliveiragarciamateos seroprevalenceofantisarscov2amongblooddonorsinriodejaneirobrazil
AT antoniocarlosmonteiroponcedeleon seroprevalenceofantisarscov2amongblooddonorsinriodejaneirobrazil
AT robertodeandrademedronho seroprevalenceofantisarscov2amongblooddonorsinriodejaneirobrazil
AT valdileagoncalvesveloso seroprevalenceofantisarscov2amongblooddonorsinriodejaneirobrazil
AT josianeiolefrancalopes seroprevalenceofantisarscov2amongblooddonorsinriodejaneirobrazil
AT luiscristovaodemoraessobrinoporto seroprevalenceofantisarscov2amongblooddonorsinriodejaneirobrazil
AT alexandrechieppe seroprevalenceofantisarscov2amongblooddonorsinriodejaneirobrazil
AT guilhermeloureirowerneck seroprevalenceofantisarscov2amongblooddonorsinriodejaneirobrazil